Understand the licensing requirements before you import, wholesale and manufacture cell, tissue or gene therapy products (CTGTP) in Singapore.
Companies dealing in the manufacture, import and wholesale of CTGTP are termed manufacturers, importers or wholesalers respectively. The regulatory control of a manufacturer, importer or wholesaler is dependent on the degree of manipulation of the CTGTP which they are dealing in.
Manufacturers, importers and wholesalers handling minimally manipulated CTGTP do not require licences but are required to notify HSA prior the start of their manufacturing, importing or wholesaling activities. They are also required to comply with the respective duties and obligations as specified in the CTGTP Regulations.
Manufacturers, importers and wholesalers handling a CTGTP which is not minimally manipulated, must obtain the required licences as follows.
An importer’s licence for CTGTP (CTGTPIL) and a wholesaler’s licence for CTGTP (CTGTPWL) are required for the import and wholesale of CTGTP, respectively. Your company must comply with the Good Distribution Practice (GDP) standard before these licences are granted to you.
If you are the product registrant and have outsourced the import and wholesale activities (including the invoicing to another company), you do not need to hold these licences yourself. However, the above licensing requirements and GDP compliance apply to the company that you have outsourced the activities to.
If your company is involved in both import and wholesale of CTGTP, you may bundle the applications for both the importer's licence (CTGTPIL) and wholesaler's licence (CTGTPWL). The fee of a bundled application is lower than the application fees of separate licences. However, you cannot apply the bundling of licences if your company’s importer’s licence is for restricted activity only.
Companies who import unregistered CTGTP for named patient(s) will require an approval via the Special Access Route (SAR) from our Advanced Therapy Products Branch prior to each import. In addition, a CTGTPWL is also required if the company is importing the unregistered CTGTP on behalf of the healthcare institution where the patient is being treated.
If your company is only involved with these activities, you can apply for a CTGTPIL (Limited Scope) at a lower fee. You may further decide if you should apply for an annual (valid for multiple consignments over one year) or a single consignment (one-time only) CTGTPIL (Limited Scope), according to your company's operational needs.
A CTGTPWL is not required for the wholesale of CTGTP imported under the CTGTPIL (Limited Scope).
You do not need to apply for an importer's licence (CTGTPIL) or a wholesaler's licence (CTGTPWL) in this case.
However, you will need to submit a Clinical Research Material (CRM) notification to our Innovation Office & Clinical Trials Branch prior to the import and supply of an unregistered CTGTP for use as CRM.
If you hold a valid manufacturer's licence for CTGTP (CTGTPML), you do not need a:
The CTGTPIL or CTGTPWL holders must appoint one or more persons as a Responsible Person to be named in each licence. The Responsible Person must discharge the duties imposed by the terms of the licence and should be contactable by the Authority at any time. This person is employed and appointed by the licensee to implement and maintain an effective quality management system that meets the Good Distribution Practice (GDP) standard where required. There is no professional certificate requirement for the responsible person.
The Responsible Person must have:
All local manufacturing facilities (including contract manufacturers, healthcare institutions and commercial manufacturers) engaged in the manufacture (including secondary packaging) of CTGTP must have a valid manufacturer's licence for CTGTP (CTGTPML). Your company must comply with the HSA Guidelines on Good Manufacturing Practice (GMP) for CTGTP before the CTGTPML is granted.
If you hold a valid CTGTPML, you do not need:
You do not need to apply for a CTGTP manufacturer’s licence (CTGTPML) in this case.
However, you will need to submit a Clinical Research Material (CRM) notification to the Innovation Office & Clinical Trials Branch prior to the manufacture of an unregistered CTGTP for use as CRM.
Healthcare institutions (HCI) manufacturing unregistered Class 2 CTGTP for supply to patients are not required to register the product. However, the HCIs must comply with the following:
In addition, HCIs or contract manufacturers engaged by the HCIs must obtain a CTGTPML for the manufacture of a CTGTP which is not minimally manipulated.
The CTGTPML holder must appoint Responsible Persons (RPs) to be named in the licence for production and quality operations.
The RPs must discharge the duties imposed by the terms of the licence and should be contactable by the Authority at any time. The RP must be employed and appointed by the licensee to implement and maintain an effective quality management system (QMS) that meets HSA Guidelines on Good Manufacturing Practice (GMP) for CTGTP. There is no professional certificate requirement for the RPs.
The RPs must have:
Regulatory overview
Class 1 CTGTP notification
Register a Class 2 CTGTP
Variation applications
Dealer's notice
Dealer's licensing and certification
Risk management plan requirements
Report adverse events
Report or recall defective products
Clinical trials
Product consultation
Advertisements and promotions
Certificate of a Pharmaceutical Product
Duties And Obligations
Guidance documents
Fees and turnaround time
Notified Class 1 CTGTP
Register of Class 2 CTGTP
Register of Licensed CTGTP Importers, Wholesalers and Manufacturers
CTGTP E-services